NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE164826 Query DataSets for GSE164826
Status Public on Jun 05, 2021
Title ELMO1 is a promoter of osteoclast function and bone loss
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Osteoporosis and bone fractures affect millions of men and women worldwide and are often due to increased bone resorption (bone loss) mediated by osteoclasts. Here, we identify a novel role for the cytoplasmic protein ELMO1 as an important ‘signaling node’ controlling the bone resorption function of osteoclasts. Initially, we noted association of ELMO1 SNPs with bone abnormalities and altered bone density in humans. Experimentally, ELMO1 emerged as a promoter of bone loss wherein deletion of ELMO1 reversed osteoporosis / bone erosions in four in vivo mouse models: osteoprotegerin deficiency, ovariectomy, and two types of inflammatory arthritis. However, ELMO1 did not promote bone loss under homeostatic conditions. Mechanistic studies pointed to a larger ELMO1 signaling network that regulates osteoclast activity at several levels. First, transcriptomics coupled with CRISPR/Cas9 genetic deletion approaches identified new regulators of osteoclast function associated with Elmo1, including cathepsin G and myeloperoxidase. Second, defining the ‘ELMO1 interactome’ in osteoclasts via proteomics revealed membrane proteins and v-ATPases required for bone degradation. Third, ELMO1 affects the formation of the actin ring /sealing zone on bone-like surfaces and the distribution of osteoclast-specific proteases. Finally, a 3D structure-based inhibitory peptide targeting a highly conserved region of ELMO1 reduced bone resorption in wild type osteoclasts. Collectively, these data identify ELMO1 as a signaling hub that regulates osteoclast function and bone loss, with relevance to diseases such as osteoporosis and arthritis.
 
Overall design The experiment consisted of two conditions - mature osteoclasts differentiated from the bone marrow of either Elmo1+/– or Elmo1–/– mice. Each condition consisted of four biological replicates.
 
Contributor(s) Arandjelovic S, Perry JA, Zhou M, Ceroi A, Smirnov I, Walk SF, Shankman LS, Cambre I, Onengut-Gumuscu S, Elevaut D, Conrads TP, Ravichandran KS
Citation(s) 34404802
Submission date Jan 14, 2021
Last update date Sep 04, 2021
Contact name Justin Shaun Arnold Perry
E-mail(s) perryj@mskcc.org
Phone 6468883928
Organization name Sloan Kettering Institute for Cancer Research
Department Immunology Program
Lab Perry Lab
Street address 408 East 69th Street, 408-15
City New York
State/province New York
ZIP/Postal code 10065
Country USA
 
Platforms (1)
GPL19057 Illumina NextSeq 500 (Mus musculus)
Samples (8)
GSM5020354 WT-1
GSM5020355 WT-2
GSM5020356 WT-3
Relations
BioProject PRJNA692169
SRA SRP301756

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE164826_DESeq2.csv.gz 2.0 Mb (ftp)(http) CSV
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap